Novanta (NASDAQ:NOVT) Issues Q4 2026 Earnings Guidance

Novanta (NASDAQ:NOVT) updated its fourth quarter 2026 earnings guidance on Tuesday. The company provided EPS guidance of 0.910-0.960 for the period, compared to the consensus earnings per share estimate of 1.020. The company issued revenue guidance of $306.0 million-$312.0 million, compared to the consensus revenue estimate of $308.6 million. Novanta also updated its FY 2026 guidance to 3.660-3.710 EPS.

Novanta Price Performance

Shares of NOVT opened at $145.98 on Tuesday. The company has a market capitalization of $5.52 billion, a P/E ratio of 93.58 and a beta of 1.71. The company has a quick ratio of 3.79, a current ratio of 4.57 and a debt-to-equity ratio of 0.12. The firm has a 50 day moving average of $142.25 and a 200 day moving average of $142.59. Novanta has a twelve month low of $98.27 and a twelve month high of $176.38.

Novanta (NASDAQ:NOVT) last announced its quarterly earnings data on Monday, November 9th. The technology company reported $1.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.97 by $0.08. The company had revenue of $305.01 million during the quarter, compared to analyst estimates of $301.02 million. Novanta had a net margin of 6.00% and a return on equity of 10.83%. The firm’s revenue for the quarter was up 23.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.87 EPS. As a group, equities research analysts anticipate that Novanta will post 3.70 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. Robert W. Baird set a $194.00 price target on Novanta in a research note on Friday, August 7th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Novanta in a report on Tuesday, October 13th. Wall Street Zen raised Novanta from a “hold” rating to a “buy” rating in a research report on Saturday. Finally, Zacks Research downgraded Novanta from a “strong-buy” rating to a “hold” rating in a report on Tuesday, October 6th. One analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $194.00.

About Novanta

Novanta develops and manufactures precision technologies used in medical and advanced industrial applications. Its products include photonics and laser components, precision motion-control systems, machine-vision technologies, and related equipment and software.

The company’s technologies are used in areas such as medical and surgical systems, life sciences, robotics, and industrial automation. Novanta serves customers internationally, with operations and customers across North America, Europe, and Asia.

Novanta was formerly known as GSI Group and adopted the Novanta name in 2016.